|1.||Park, Yong Jin: 2 articles (11/2012 - 01/2011)|
|2.||Klein, Oliver J: 2 articles (11/2012 - 01/2011)|
|3.||Evans, Conor L: 2 articles (11/2012 - 01/2011)|
|4.||Fang, Yong: 1 article (07/2014)|
|5.||Fu, Xiu-Jun: 1 article (07/2014)|
|6.||Zhu, Yun-Qing: 1 article (07/2014)|
|7.||Hu, Yi-Ping: 1 article (07/2014)|
|8.||Du, Jian-Zhong: 1 article (07/2014)|
|9.||Lu, Hua-Xiang: 1 article (07/2014)|
|10.||Yao, Min: 1 article (07/2014)|
01/01/2011 - "To overcome these limitations and eliminate otherwise spared cancer cells, we utilized the cationic photosensitizer EtNBS to treat hypoxic regions deep inside in vitro 3D models of metastatic ovarian cancer. "
09/01/1998 - "In this preliminary study, dogs and cats with naturally occurring tumors were treated with EtNBS-PDT to determine safety and efficacy. "
11/05/2012 - "In vitro optimization of EtNBS-PDT against hypoxic tumor environments with a tiered, high-content, 3D model optical screening platform."
01/01/2011 - "Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT."
09/01/1998 - "EtNBS-PDT is safe for dogs and cats and has activity against selected naturally occurring tumors, with an overall objective response rate (partial response + CR) of 61.5%."
|3.||Phototoxic Dermatitis (Phototoxicity)
|4.||Wounds and Injuries (Trauma)
|5.||Ovarian Neoplasms (Ovarian Cancer)
|3.||Photosensitizing Agents (Photosensitizers)
|1.||Photochemotherapy (Photodynamic Therapy)